Swiss National Bank’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Swiss National Bank’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-63,050	Closed	-$3.25M	–	2668
2016 Q1	$3.25M	Buy	63,050 +12,350	+24%	+$912K	0.01%	1120
2015 Q4	$5.73M	Buy	50,700 +300	+0.6%	+$33K	0.01%	734
2015 Q3	$5.93M	Buy	50,400 +6,800	+16%	+$888K	0.02%	702
2015 Q2	$3.38M	Buy	43,600 +800	+2%	+$52.5K	0.01%	984
2015 Q1	$2.48M	Buy	42,800 +5,300	+14%	+$225K	0.01%	1152
2014 Q4	$1.21M	Buy	37,500 +2,000	+6%	+$60K	﹤0.01%	1619
2014 Q3	$869K	Hold	35,500	–	–	﹤0.01%	1747
2014 Q2	$629K	Buy	+35,500	New	+$572K	﹤0.01%	2030

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Swiss National Bank's ANAC Position: Q2 2016 in Review

Swiss National Bank sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 63,050 shares — an estimated $3.25M sold.

Swiss National Bank first reported a position in ANAC in Q2 2014 and held it in 8 quarters. The position peaked at $5.93M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Swiss National Bank reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Swiss National Bank sold 63,050 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.25M.
Swiss National Bank first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 8 quarters.
Swiss National Bank's ANACOR PHARMACEUTICALS INC COM position peaked at $5.93M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.